Similar articles for PMID: 16330573

Year	Number of Results
1957	1
1959	1
1962	2
1963	2
1964	1
1965	1
1976	3
1977	2
1980	2
1982	1
1983	1
1985	1
1986	1
1987	2
1988	2
1989	5
1991	4
1992	3
1993	7
1994	4
1995	3
1996	4
1997	4
1998	6
1999	3
2000	5
2001	7
2002	9
2003	7
2004	6
2005	9
2006	5
2007	6
2008	4
2009	7
2010	5
2011	8
2012	5
2013	2
2014	3
2015	8
2016	5
2018	4
2019	3
2020	3
2021	5
2022	5
2023	2
2024	0

1

Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.

Essman SC, Lewis MR, Miller WH. Essman SC, et al. J Nucl Med. 2005 Dec;46(12):2076-82. J Nucl Med. 2005. PMID: 16330573 Free article.

2

Effects of 153Sm-ethylenediaminetetramethylene phosphonate on physeal and articular cartilage in juvenile rabbits.

Essman SC, Lattimer J, Cook JL, Turnquist S, Kuroki K. Essman SC, et al. J Nucl Med. 2003 Sep;44(9):1510-5. J Nucl Med. 2003. PMID: 12960200 Free article.

3

Effects of increasing doses of samarium-153-ethylenediaminetetramethylene phosphonate on axial and appendicular skeletal growth in juvenile rabbits.

Essman SC, Lewis MR, Fox DB. Essman SC, et al. Nucl Med Biol. 2008 Feb;35(2):219-25. doi: 10.1016/j.nucmedbio.2007.11.005. Nucl Med Biol. 2008. PMID: 18312832

4

Samarium-153 EDTMP therapy of disseminated skeletal metastasis.

Turner JH, Martindale AA, Sorby P, Hetherington EL, Fleay RF, Hoffman RF, Claringbold PG. Turner JH, et al. Eur J Nucl Med. 1989;15(12):784-95. doi: 10.1007/BF00255498. Eur J Nucl Med. 1989. PMID: 2483138

5

Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.

Bayouth JE, Macey DJ, Kasi LP, Fossella FV. Bayouth JE, et al. J Nucl Med. 1994 Jan;35(1):63-9. J Nucl Med. 1994. PMID: 7505819 Free article. Clinical Trial.

6

ESR dosimetry of 89Sr and 153Sm in bone.

Kinoshita A, Braga FJ, Graeff CF, Baffa O. Kinoshita A, et al. Appl Radiat Isot. 2001 Feb;54(2):269-74. doi: 10.1016/s0969-8043(00)00159-7. Appl Radiat Isot. 2001. PMID: 11200888

7

[Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases].

Fan W, Chen LX, Liu XW, Tang Q, Wang GH, Zhi SF, Zeng ZY. Fan W, et al. Ai Zheng. 2006 Nov;25(11):1395-8. Ai Zheng. 2006. PMID: 17094908 Chinese.

8

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.

Anderson P, Nuñez R. Anderson P, et al. Expert Rev Anticancer Ther. 2007 Nov;7(11):1517-27. doi: 10.1586/14737140.7.11.1517. Expert Rev Anticancer Ther. 2007. PMID: 18020921 Review.

9

Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMP.

Yousefnia H, Zolghadri S. Yousefnia H, et al. Phys Med. 2015 Nov;31(7):714-9. doi: 10.1016/j.ejmp.2015.05.015. Epub 2015 Jun 19. Phys Med. 2015. PMID: 26095757

10

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD Jr, Scott T, Schwartz CL. Loeb DM, et al. Cancer. 2009 Jun 1;115(11):2514-22. doi: 10.1002/cncr.24286. Cancer. 2009. PMID: 19338063 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year